56% overturnedAppeal outcomes · Home & equipment

Denied specialty bed or support surface: what independent reviewers actually decided

Support-surface denials were decided on the patient's position and skin, and the winning records were unusually concrete.

Hospital beds, powered pressure-reducing mattresses and related support surfaces supplied for home use, reviewed against criteria tied to mobility, skin integrity and positioning need.

What the independent reviewers decided

56%

overturned by the independent reviewer

36

of 64 decisions in the corpus

Source

California DMHC independent medical review determinations, 2017-2026. Public record.

Read this as a base rate, not as your odds

These are decisions about other patients, in one state, that had already been through the plan's own internal appeal and were then sent to an outside reviewer. That population is self-selected toward disputes worth pursuing, so the rate says what happened to cases like this at that stage — not what will happen to a specific claim. It is not medical or legal advice.

Why plans deny specialty bed or support surface

  • The policy holds that an ordinary bed with repositioning would suffice.
  • The wound stage or skin findings the criteria require are not documented.
  • A lower-tier surface is deemed adequate for the documented risk.
  • The equipment is characterised as convenience for the caregiver.

What actually carried the cases that won

Functional impact appeared in 81% of the reversals — the second-highest functional signal in this corpus — with severity at 53%. That describes a record built on position and consequence: what the patient can and cannot do in bed, what the skin shows, and what has already happened. The reversals carried wound staging, measurements and a repositioning history. Where the plan proposed a lower tier, the successful files said what that tier would not prevent.

What the record showedShare of overturned decisions
The functional impact on the patient was documented81%
The severity or urgency was documented53%
Conservative treatment was documented as failed28%
The diagnosis was confirmed22%
A published guideline supported the request11%
The condition was documented as chronic or long-standing11%
Prior treatment was documented6%
Objective findings were documented6%

Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.

What the reviewers cited

  • Peer-reviewed literature — in 17% of the overturned decisions
  • Specialty-society criteria — in 6% of the overturned decisions
  • FDA labeling — in 3% of the overturned decisions
  • Clinical guidelines — in 3% of the overturned decisions

specialty bed or support surface denials — frequently asked

Is a denied specialty bed worth appealing?
Just over half were reversed: 36 out of 64 California determinations.
What does the record need to contain?
Position and skin. Functional impact appeared in 81% of the reversals: what the patient cannot do unaided, the wound stage and measurements if there is a wound, and what repositioning has already been attempted.
How is a lower-tier substitution answered?
By naming what it would not prevent for this patient — the pressure point, the wound trajectory, the positioning need — rather than restating the request.

Related guides

CO-50 — not medically necessaryBenefit exclusion denialsMedical necessity appeal letters

Source

Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.

Appeal a denial →